应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
IOVA Iovance Biotherapeutics, Inc.
未开盘 12-20 16:00:00 EST
7.38
+0.16
+2.22%
盘后
7.48
+0.10
+1.36%
19:59 EST
最高
7.44
最低
7.07
成交量
1,118万
今开
7.17
昨收
7.22
日振幅
5.12%
总市值
22.49亿
流通市值
16.59亿
总股本
3.05亿
成交额
8,225万
换手率
4.97%
流通股本
2.25亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Iovance Biotherapeutics, Inc.盘中异动 股价大跌5.01%
市场透视 · 12-13
Iovance Biotherapeutics, Inc.盘中异动 股价大跌5.01%
Iovance Biotherapeutics, Inc.盘中异动 股价大涨5.31%报8.92美元
市场透视 · 12-06
Iovance Biotherapeutics, Inc.盘中异动 股价大涨5.31%报8.92美元
Iovance Biotherapeutics, Inc.盘中异动 股价大涨5.04%
市场透视 · 11-28
Iovance Biotherapeutics, Inc.盘中异动 股价大涨5.04%
Iovance Biotherapeutics, Inc.盘中异动 早盘股价大涨5.67%报9.04美元
市场透视 · 11-25
Iovance Biotherapeutics, Inc.盘中异动 早盘股价大涨5.67%报9.04美元
Iovance Biotherapeutics, Inc.盘中异动 临近午盘股价大涨5.10%报8.66美元
市场透视 · 11-23
Iovance Biotherapeutics, Inc.盘中异动 临近午盘股价大涨5.10%报8.66美元
Iovance Biotherapeutics, Inc.盘中异动 早盘大幅上涨5.01%
市场透视 · 11-19
Iovance Biotherapeutics, Inc.盘中异动 早盘大幅上涨5.01%
Iovance Biotherapeutics, Inc.2024财年第三财季实现净利润-83.54百万美元,同比增加26.72%
市场透视 · 11-17
Iovance Biotherapeutics, Inc.2024财年第三财季实现净利润-83.54百万美元,同比增加26.72%
Iovance Biotherapeutics, Inc.盘中异动 快速下挫5.14%
市场透视 · 11-12
Iovance Biotherapeutics, Inc.盘中异动 快速下挫5.14%
Iovance Biotherapeutics, Inc.盘中异动 快速下挫5.05%报10.05美元
市场透视 · 11-11
Iovance Biotherapeutics, Inc.盘中异动 快速下挫5.05%报10.05美元
Iovance Biotherapeutics, Inc.盘中异动 快速下跌13.53%
市场透视 · 11-08
Iovance Biotherapeutics, Inc.盘中异动 快速下跌13.53%
Iovance Biotherapeutics Inc 预计每股亏损30美分 - 财报前瞻
路透中文 · 11-06
Iovance Biotherapeutics Inc 预计每股亏损30美分 - 财报前瞻
Iovance Biotherapeutics, Inc.盘中异动 早盘急速上涨5.06%
市场透视 · 11-06
Iovance Biotherapeutics, Inc.盘中异动 早盘急速上涨5.06%
Iovance Biotherapeutics, Inc.盘中异动 股价大涨5.12%报10.98美元
市场透视 · 11-02
Iovance Biotherapeutics, Inc.盘中异动 股价大涨5.12%报10.98美元
Iovance Biotherapeutics, Inc.盘中异动 大幅下跌5.14%
市场透视 · 10-31
Iovance Biotherapeutics, Inc.盘中异动 大幅下跌5.14%
Iovance Biotherapeutics, Inc.盘中异动 下午盘大幅拉升5.01%报11.21美元
市场透视 · 10-29
Iovance Biotherapeutics, Inc.盘中异动 下午盘大幅拉升5.01%报11.21美元
Iovance Biotherapeutics, Inc.盘中异动 早盘大幅上涨5.02%
市场透视 · 10-25
Iovance Biotherapeutics, Inc.盘中异动 早盘大幅上涨5.02%
Iovance Biotherapeutics, Inc.盘中异动 早盘快速拉升5.01%报10.31美元
市场透视 · 10-24
Iovance Biotherapeutics, Inc.盘中异动 早盘快速拉升5.01%报10.31美元
Iovance Biotherapeutics, Inc.盘中异动 早盘股价大跌5.13%
市场透视 · 10-21
Iovance Biotherapeutics, Inc.盘中异动 早盘股价大跌5.13%
Iovance Biotherapeutics, Inc.盘中异动 快速上涨5.02%报9.84美元
市场透视 · 10-18
Iovance Biotherapeutics, Inc.盘中异动 快速上涨5.02%报9.84美元
Iovance Biotherapeutics, Inc.盘中异动 下午盘急速跳水5.07%
市场透视 · 10-08
Iovance Biotherapeutics, Inc.盘中异动 下午盘急速跳水5.07%
暂无数据
公司概况
公司名称:
Iovance Biotherapeutics, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Iovance Biotherapeutics, Inc.是一家新兴的生物技术公司,专注于培养细胞,使用自体肿瘤浸润淋巴细胞(TIL)治疗转移性黑色素瘤等实体瘤的细胞治疗方法的发展和商业化。该公司于2007年9月17日在内华达州成立。
发行价格:
--
{"stockData":{"symbol":"IOVA","market":"US","secType":"STK","nameCN":"Iovance Biotherapeutics, Inc.","latestPrice":7.38,"timestamp":1734728400000,"preClose":7.22,"halted":0,"volume":11178037,"hourTrading":{"tag":"盘后","latestPrice":7.4806,"preClose":7.38,"latestTime":"19:59 EST","volume":2132389,"amount":15737305.0373,"timestamp":1734742789342},"delay":0,"floatShares":224816642,"shares":304780790,"eps":-1.477851,"marketStatus":"未开盘","marketStatusCode":0,"change":0.16,"latestTime":"12-20 16:00:00 EST","open":7.17,"high":7.44,"low":7.07,"amount":82252886.637187,"amplitude":0.051247,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.477851,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1734944400000},"adr":0,"adjPreClose":7.22,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":7.18,"preClose":7.22,"latestTime":"09:28 EST","volume":22867,"amount":163082.504728,"timestamp":1734704880028},"postHourTrading":{"tag":"盘后","latestPrice":7.4806,"preClose":7.38,"latestTime":"19:59 EST","volume":2132389,"amount":15737305.0373,"timestamp":1734742789342},"volumeRatio":1.7604202580824895,"optionData":{"bulkOrders":[{"symbol":"IOVA","call":true,"expireDate":1737090000000,"strike":"7.5","timestamp":1734724211690,"price":0.6200000047683716,"volume":1998,"amount":123876,"type":"+"}]},"impliedVol":0.8035,"impliedVolPercentile":0.3611},"requestUrl":"/m/hq/s/IOVA/tweets","defaultTab":"tweets","newsList":[{"id":"2491833755","title":"Iovance Biotherapeutics, Inc.盘中异动 股价大跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2491833755","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491833755?lang=zh_cn&edition=full","pubTime":"2024-12-13 01:42","pubTimestamp":1734025341,"startTime":"0","endTime":"0","summary":"北京时间2024年12月13日01时42分,Iovance Biotherapeutics, Inc.股票出现异动,股价大幅下跌5.01%。Iovance Biotherapeutics, Inc.股票所在的生物技术行业中,整体跌幅为1.08%。Iovance Biotherapeutics, Inc.公司简介:Iovance Biotherapeutics Inc 是一家临床阶段的生物制药公司,通过利用人体免疫系统识别和摧毁多种癌细胞的能力,为每位患者提供个性化治疗,开创了治疗癌症的变革性方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213014221a1e9a644&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213014221a1e9a644&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IOVA","BK4139"],"gpt_icon":0},{"id":"2489522232","title":"Iovance Biotherapeutics, Inc.盘中异动 股价大涨5.31%报8.92美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2489522232","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489522232?lang=zh_cn&edition=full","pubTime":"2024-12-06 23:12","pubTimestamp":1733497947,"startTime":"0","endTime":"0","summary":"北京时间2024年12月06日23时12分,Iovance Biotherapeutics, Inc.股票出现异动,股价大幅上涨5.31%。Iovance Biotherapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.69%。Iovance Biotherapeutics, Inc.公司简介:Iovance Biotherapeutics Inc 是一家临床阶段的生物制药公司,通过利用人体免疫系统识别和摧毁多种癌细胞的能力,为每位患者提供个性化治疗,开创了治疗癌症的变革性方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206231227a1d9859c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206231227a1d9859c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IOVA","BK4139"],"gpt_icon":0},{"id":"2486280547","title":"Iovance Biotherapeutics, Inc.盘中异动 股价大涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486280547","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486280547?lang=zh_cn&edition=full","pubTime":"2024-11-28 02:51","pubTimestamp":1732733506,"startTime":"0","endTime":"0","summary":"北京时间2024年11月28日02时51分,Iovance Biotherapeutics, Inc.股票出现波动,股价急速拉升5.04%。Iovance Biotherapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.54%。Iovance Biotherapeutics, Inc.公司简介:Iovance Biotherapeutics Inc 是一家临床阶段的生物制药公司,通过利用人体免疫系统识别和摧毁多种癌细胞的能力,为每位患者提供个性化治疗,开创了治疗癌症的变革性方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241128025146a25a6007&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241128025146a25a6007&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IOVA","BK4139"],"gpt_icon":0},{"id":"2486308083","title":"Iovance Biotherapeutics, Inc.盘中异动 早盘股价大涨5.67%报9.04美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486308083","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486308083?lang=zh_cn&edition=full","pubTime":"2024-11-25 22:31","pubTimestamp":1732545083,"startTime":"0","endTime":"0","summary":"北京时间2024年11月25日22时31分,Iovance Biotherapeutics, Inc.股票出现异动,股价大幅上涨5.67%。Iovance Biotherapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.92%。Iovance Biotherapeutics, Inc.公司简介:Iovance Biotherapeutics Inc 是一家临床阶段的生物制药公司,通过利用人体免疫系统识别和摧毁多种癌细胞的能力,为每位患者提供个性化治疗,开创了治疗癌症的变革性方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125223123971a8580&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125223123971a8580&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IOVA"],"gpt_icon":0},{"id":"2485470296","title":"Iovance Biotherapeutics, Inc.盘中异动 临近午盘股价大涨5.10%报8.66美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485470296","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485470296?lang=zh_cn&edition=full","pubTime":"2024-11-23 00:50","pubTimestamp":1732294228,"startTime":"0","endTime":"0","summary":"北京时间2024年11月23日00时50分,Iovance Biotherapeutics, Inc.股票出现波动,股价快速上涨5.10%。Iovance Biotherapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.76%。Iovance Biotherapeutics, Inc.公司简介:Iovance Biotherapeutics Inc 是一家临床阶段的生物制药公司,通过利用人体免疫系统识别和摧毁多种癌细胞的能力,为每位患者提供个性化治疗,开创了治疗癌症的变革性方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112300502898e44335&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112300502898e44335&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IOVA"],"gpt_icon":0},{"id":"2484603684","title":"Iovance Biotherapeutics, Inc.盘中异动 早盘大幅上涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484603684","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484603684?lang=zh_cn&edition=full","pubTime":"2024-11-19 00:16","pubTimestamp":1731946619,"startTime":"0","endTime":"0","summary":"北京时间2024年11月19日00时16分,Iovance Biotherapeutics, Inc.股票出现异动,股价大幅拉升5.01%。Iovance Biotherapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.10%。Iovance Biotherapeutics, Inc.公司简介:Iovance Biotherapeutics Inc 是一家临床阶段的生物制药公司,通过利用人体免疫系统识别和摧毁多种癌细胞的能力,为每位患者提供个性化治疗,开创了治疗癌症的变革性方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111900165998e434d8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111900165998e434d8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IOVA","BK4139"],"gpt_icon":0},{"id":"2484548830","title":"Iovance Biotherapeutics, Inc.2024财年第三财季实现净利润-83.54百万美元,同比增加26.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484548830","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484548830?lang=zh_cn&edition=full","pubTime":"2024-11-17 00:04","pubTimestamp":1731773040,"startTime":"0","endTime":"0","summary":"11月17日,Iovance Biotherapeutics, Inc.公布财报,公告显示公司2024财年第三财季净利润为-83.54百万美元,同比增加26.72%;其中营业收入为58.56百万美元,同比增加12386.14%,每股基本收益为-0.28美元。从资产负债表来看,Iovance Biotherapeutics, Inc.总负债2.18亿美元,其中短期债务11.55百万美元,资产负债比为4.55,流动比率为4.23。机构评级:截至2024年11月17日,当前有13家机构对Iovance Biotherapeutics, Inc.目标价做出预测,其中目标均价为23.77美元,其中最低目标价为10.00美元,最高目标价为34.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241117000519a23e0794&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241117000519a23e0794&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IOVA"],"gpt_icon":0},{"id":"2482861880","title":"Iovance Biotherapeutics, Inc.盘中异动 快速下挫5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482861880","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482861880?lang=zh_cn&edition=full","pubTime":"2024-11-12 22:52","pubTimestamp":1731423178,"startTime":"0","endTime":"0","summary":"北京时间2024年11月12日22时52分,Iovance Biotherapeutics, Inc.股票出现波动,股价急速下跌5.14%。Iovance Biotherapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.21%。Iovance Biotherapeutics, Inc.公司简介:Iovance Biotherapeutics Inc 是一家临床阶段的生物制药公司,通过利用人体免疫系统识别和摧毁多种癌细胞的能力,为每位患者提供个性化治疗,开创了治疗癌症的变革性方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111222525998e42185&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111222525998e42185&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IOVA"],"gpt_icon":0},{"id":"2482352738","title":"Iovance Biotherapeutics, Inc.盘中异动 快速下挫5.05%报10.05美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482352738","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482352738?lang=zh_cn&edition=full","pubTime":"2024-11-11 22:36","pubTimestamp":1731335806,"startTime":"0","endTime":"0","summary":"北京时间2024年11月11日22时36分,Iovance Biotherapeutics, Inc.股票出现波动,股价大幅下跌5.05%。Iovance Biotherapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.33%。Iovance Biotherapeutics, Inc.公司简介:Iovance Biotherapeutics Inc 是一家临床阶段的生物制药公司,通过利用人体免疫系统识别和摧毁多种癌细胞的能力,为每位患者提供个性化治疗,开创了治疗癌症的变革性方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111223647971a5b33&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111223647971a5b33&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IOVA","BK4139"],"gpt_icon":0},{"id":"2481101674","title":"Iovance Biotherapeutics, Inc.盘中异动 快速下跌13.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481101674","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481101674?lang=zh_cn&edition=full","pubTime":"2024-11-08 22:31","pubTimestamp":1731076306,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日22时31分,Iovance Biotherapeutics, Inc.股票出现波动,股价急速下跌13.53%。Iovance Biotherapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.56%。Iovance Biotherapeutics, Inc.公司简介:Iovance Biotherapeutics Inc 是一家临床阶段的生物制药公司,通过利用人体免疫系统识别和摧毁多种癌细胞的能力,为每位患者提供个性化治疗,开创了治疗癌症的变革性方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110822314695bdeee4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110822314695bdeee4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IOVA"],"gpt_icon":0},{"id":"2481883489","title":"Iovance Biotherapeutics Inc 预计每股亏损30美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2481883489","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481883489?lang=zh_cn&edition=full","pubTime":"2024-11-06 22:33","pubTimestamp":1730903615,"startTime":"0","endTime":"0","summary":"Iovance Biotherapeutics Inc 预计每股亏损30美分 - 财报前瞻Iovance Biotherapeutics Inc IOVA.OQ IOVA.O将于11月7日公布截至2024年9月30日的财报,预计该公司的季度收入将有所增长。LSEG 分析师对 Iovance Biotherapeutics Inc 的平均预期是每股亏损 30 美分。华尔街对 Iovance Biotherapeutics Inc 的 12 个月目标价中位数为 24.00 美元,高于其最新收盘价 11.66 美元。11月6日 - 上一季度业绩。除非另有说明,否则所有数据均以美元为单位。如有任何其他问题或反馈,请联系 RefinitivNewsSupport@thomsonreuters.com。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241106:nL4S3MD2MZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IOVA"],"gpt_icon":0},{"id":"2481398385","title":"Iovance Biotherapeutics, Inc.盘中异动 早盘急速上涨5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481398385","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481398385?lang=zh_cn&edition=full","pubTime":"2024-11-06 22:31","pubTimestamp":1730903469,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日22时31分,Iovance Biotherapeutics, Inc.股票出现异动,股价快速拉升5.06%。Iovance Biotherapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.91%。Iovance Biotherapeutics, Inc.公司简介:Iovance Biotherapeutics Inc 是一家临床阶段的生物制药公司,通过利用人体免疫系统识别和摧毁多种癌细胞的能力,为每位患者提供个性化治疗,开创了治疗癌症的变革性方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106223109971a4b84&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106223109971a4b84&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IOVA","BK4139"],"gpt_icon":0},{"id":"2480830766","title":"Iovance Biotherapeutics, Inc.盘中异动 股价大涨5.12%报10.98美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480830766","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480830766?lang=zh_cn&edition=full","pubTime":"2024-11-02 01:48","pubTimestamp":1730483292,"startTime":"0","endTime":"0","summary":"北京时间2024年11月02日01时48分,Iovance Biotherapeutics, Inc.股票出现波动,股价快速拉升5.12%。截至发稿,该股报10.98美元/股,成交量284.289万股,换手率0.94%,振幅3.78%。Iovance Biotherapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.40%。Iovance Biotherapeutics, Inc.公司简介:Iovance Biotherapeutics Inc 是一家临床阶段的生物制药公司,通过利用人体免疫系统识别和摧毁多种癌细胞的能力,为每位患者提供个性化治疗,开创了治疗癌症的变革性方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241102014812971a3eb0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241102014812971a3eb0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IOVA","BK4139"],"gpt_icon":0},{"id":"2479032463","title":"Iovance Biotherapeutics, Inc.盘中异动 大幅下跌5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479032463","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479032463?lang=zh_cn&edition=full","pubTime":"2024-10-31 23:16","pubTimestamp":1730387805,"startTime":"0","endTime":"0","summary":"北京时间2024年10月31日23时16分,Iovance Biotherapeutics, Inc.股票出现波动,股价急速下跌5.14%。Iovance Biotherapeutics, Inc.股票所在的生物技术行业中,整体跌幅为3.57%。Iovance Biotherapeutics, Inc.公司简介:Iovance Biotherapeutics Inc 是一家临床阶段的生物制药公司,通过利用人体免疫系统识别和摧毁多种癌细胞的能力,为每位患者提供个性化治疗,开创了治疗癌症的变革性方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031231645a2029a4e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031231645a2029a4e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IOVA"],"gpt_icon":0},{"id":"2479437846","title":"Iovance Biotherapeutics, Inc.盘中异动 下午盘大幅拉升5.01%报11.21美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479437846","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479437846?lang=zh_cn&edition=full","pubTime":"2024-10-29 01:07","pubTimestamp":1730135272,"startTime":"0","endTime":"0","summary":"北京时间2024年10月29日01时07分,Iovance Biotherapeutics, Inc.股票出现波动,股价大幅拉升5.01%。Iovance Biotherapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.14%。Iovance Biotherapeutics, Inc.公司简介:Iovance Biotherapeutics Inc 是一家临床阶段的生物制药公司,通过利用人体免疫系统识别和摧毁多种癌细胞的能力,为每位患者提供个性化治疗,开创了治疗癌症的变革性方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102901075298e3ee2a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102901075298e3ee2a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IOVA","BK4139"],"gpt_icon":0},{"id":"2478935418","title":"Iovance Biotherapeutics, Inc.盘中异动 早盘大幅上涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478935418","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478935418?lang=zh_cn&edition=full","pubTime":"2024-10-25 21:49","pubTimestamp":1729864166,"startTime":"0","endTime":"0","summary":"北京时间2024年10月25日21时49分,Iovance Biotherapeutics, Inc.股票出现波动,股价急速拉升5.02%。Iovance Biotherapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.66%。Iovance Biotherapeutics, Inc.公司简介:Iovance Biotherapeutics Inc 是一家临床阶段的生物制药公司,通过利用人体免疫系统识别和摧毁多种癌细胞的能力,为每位患者提供个性化治疗,开创了治疗癌症的变革性方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025214926971a2550&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025214926971a2550&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IOVA"],"gpt_icon":0},{"id":"2477263970","title":"Iovance Biotherapeutics, Inc.盘中异动 早盘快速拉升5.01%报10.31美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477263970","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477263970?lang=zh_cn&edition=full","pubTime":"2024-10-24 21:37","pubTimestamp":1729777072,"startTime":"0","endTime":"0","summary":"北京时间2024年10月24日21时37分,Iovance Biotherapeutics, Inc.股票出现异动,股价大幅拉升5.01%。Iovance Biotherapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.39%。Iovance Biotherapeutics, Inc.公司简介:Iovance Biotherapeutics Inc 是一家临床阶段的生物制药公司,通过利用人体免疫系统识别和摧毁多种癌细胞的能力,为每位患者提供个性化治疗,开创了治疗癌症的变革性方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102421375398e3e3db&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102421375398e3e3db&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IOVA","BK4139"],"gpt_icon":0},{"id":"2477386475","title":"Iovance Biotherapeutics, Inc.盘中异动 早盘股价大跌5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477386475","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477386475?lang=zh_cn&edition=full","pubTime":"2024-10-21 23:01","pubTimestamp":1729522917,"startTime":"0","endTime":"0","summary":"北京时间2024年10月21日23时01分,Iovance Biotherapeutics, Inc.股票出现异动,股价急速下跌5.13%。Iovance Biotherapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.45%。Iovance Biotherapeutics, Inc.公司简介:Iovance Biotherapeutics Inc 是一家临床阶段的生物制药公司,通过利用人体免疫系统识别和摧毁多种癌细胞的能力,为每位患者提供个性化治疗,开创了治疗癌症的变革性方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102123015898e3d90a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102123015898e3d90a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IOVA"],"gpt_icon":0},{"id":"2476485268","title":"Iovance Biotherapeutics, Inc.盘中异动 快速上涨5.02%报9.84美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2476485268","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476485268?lang=zh_cn&edition=full","pubTime":"2024-10-18 01:48","pubTimestamp":1729187317,"startTime":"0","endTime":"0","summary":"北京时间2024年10月18日01时48分,Iovance Biotherapeutics, Inc.股票出现异动,股价大幅上涨5.02%。Iovance Biotherapeutics, Inc.股票所在的生物技术行业中,整体涨幅为1.02%。Iovance Biotherapeutics, Inc.公司简介:Iovance Biotherapeutics Inc 是一家临床阶段的生物制药公司,通过利用人体免疫系统识别和摧毁多种癌细胞的能力,为每位患者提供个性化治疗,开创了治疗癌症的变革性方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241018014837971a0e4b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241018014837971a0e4b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IOVA"],"gpt_icon":0},{"id":"2473384484","title":"Iovance Biotherapeutics, Inc.盘中异动 下午盘急速跳水5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2473384484","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473384484?lang=zh_cn&edition=full","pubTime":"2024-10-08 01:56","pubTimestamp":1728323763,"startTime":"0","endTime":"0","summary":"北京时间2024年10月08日01时56分,Iovance Biotherapeutics, Inc.股票出现异动,股价急速下挫5.07%。Iovance Biotherapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.09%。Iovance Biotherapeutics, Inc.公司简介:Iovance Biotherapeutics Inc 是一家临床阶段的生物制药公司,通过利用人体免疫系统识别和摧毁多种癌细胞的能力,为每位患者提供个性化治疗,开创了治疗癌症的变革性方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410080156039719eb38&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410080156039719eb38&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IOVA"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.iovance.com","stockEarnings":[{"period":"1week","weight":-0.0575},{"period":"1month","weight":-0.0934},{"period":"3month","weight":-0.2729},{"period":"6month","weight":-0.0787},{"period":"1year","weight":-0.0646},{"period":"ytd","weight":-0.0923}],"compareEarnings":[{"period":"1week","weight":-0.0221},{"period":"1month","weight":0.0006},{"period":"3month","weight":0.0397},{"period":"6month","weight":0.0851},{"period":"1year","weight":0.2499},{"period":"ytd","weight":0.243}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Iovance Biotherapeutics, Inc.是一家新兴的生物技术公司,专注于培养细胞,使用自体肿瘤浸润淋巴细胞(TIL)治疗转移性黑色素瘤等实体瘤的细胞治疗方法的发展和商业化。该公司于2007年9月17日在内华达州成立。","yearOnYearQuotes":[{"month":1,"riseRate":0.444444,"avgChangeRate":0.066181},{"month":2,"riseRate":0.555556,"avgChangeRate":0.167188},{"month":3,"riseRate":0.2,"avgChangeRate":-0.027658},{"month":4,"riseRate":0.3,"avgChangeRate":-0.022763},{"month":5,"riseRate":0.4,"avgChangeRate":-0.049074},{"month":6,"riseRate":0.5,"avgChangeRate":0.159675},{"month":7,"riseRate":0.7,"avgChangeRate":0.002291},{"month":8,"riseRate":0.4,"avgChangeRate":0.012998},{"month":9,"riseRate":0.3,"avgChangeRate":-0.084178},{"month":10,"riseRate":0.5,"avgChangeRate":-0.015002},{"month":11,"riseRate":0.7,"avgChangeRate":0.052334},{"month":12,"riseRate":0.6,"avgChangeRate":0.046216}],"exchange":"NASDAQ","name":"Iovance Biotherapeutics, Inc.","nameEN":"Iovance Biotherapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Iovance Biotherapeutics, Inc.(IOVA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Iovance Biotherapeutics, Inc.(IOVA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Iovance Biotherapeutics, Inc.,IOVA,Iovance Biotherapeutics, Inc.股票,Iovance Biotherapeutics, Inc.股票老虎,Iovance Biotherapeutics, Inc.股票老虎国际,Iovance Biotherapeutics, Inc.行情,Iovance Biotherapeutics, Inc.股票行情,Iovance Biotherapeutics, Inc.股价,Iovance Biotherapeutics, Inc.股市,Iovance Biotherapeutics, Inc.股票价格,Iovance Biotherapeutics, Inc.股票交易,Iovance Biotherapeutics, Inc.股票购买,Iovance Biotherapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Iovance Biotherapeutics, Inc.(IOVA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Iovance Biotherapeutics, Inc.(IOVA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}